Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
Anthony K. L. Leung, Diane E. Griffin, Jürgen Bosch, et al.
Pathogens (2022) Vol. 11, Iss. 1, pp. 94-94
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 87
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
Pulak Kar, Chatrin Chatrin, N Mimica Dukic, et al.
The EMBO Journal (2024) Vol. 43, Iss. 14, pp. 2929-2953
Open Access | Times Cited: 15
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 37
PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools
Morgan Dasovich, Anthony K. L. Leung
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1552-1572
Open Access | Times Cited: 32
Pro-Viral and Anti-Viral Roles of the RNA-Binding Protein G3BP1
Aravinth Kumar Jayabalan, Diane E. Griffin, Anthony K. L. Leung
Viruses (2023) Vol. 15, Iss. 2, pp. 449-449
Open Access | Times Cited: 23
Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation
Victória Chaves Ribeiro, Lilian C. Russo, Nícolas C. Hoch
The EMBO Journal (2024) Vol. 43, Iss. 14, pp. 2908-2928
Open Access | Times Cited: 8
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
Anu Roy, Yousef M. Alhammad, Peter R. McDonald, et al.
Antiviral Research (2022) Vol. 203, pp. 105344-105344
Open Access | Times Cited: 29
Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins
Sofia E. Delgado-Rodriguez, Andrew P. Ryan, Matthew D. Daugherty
Pathogens (2023) Vol. 12, Iss. 5, pp. 674-674
Open Access | Times Cited: 15
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
(2025)
Open Access
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
(2025)
Open Access
Zinc-finger PARP proteins ADP-ribosylate alphaviral proteins and are required for interferon-γ–mediated antiviral immunity
Andrew P. Ryan, Sofia E. Delgado-Rodriguez, Matthew D. Daugherty
Science Advances (2025) Vol. 11, Iss. 5
Open Access
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
M. Schuller, Tryfon Zarganes‐Tzitzikas, James M. Bennett, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 324-324
Open Access | Times Cited: 13
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives
Giuseppe Manco, Giuseppina Lacerra, Elena Porzio, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 443-443
Open Access | Times Cited: 21
Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain
Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 67, pp. 116788-116788
Open Access | Times Cited: 19
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell‐based approaches
Meenakshi Chaudhary, Akash Kumar, Kiran Bala Sharma, et al.
FEBS Journal (2024) Vol. 291, Iss. 12, pp. 2656-2673
Closed Access | Times Cited: 2
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening
Jasmin C. Aschenbrenner, André S. Godoy, M. Fairhead, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
SAR based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against COVID-19: A Medicinal Chemist Perspective
Anish Madan, Mansi Garg, Garvit Satija, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 14, pp. 1319-1339
Closed Access | Times Cited: 6
The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies
Giuliana Catara, Rocco Caggiano, Luca Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 240-240
Open Access | Times Cited: 6
Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Deep learning identified genetic variants for COVID‐19‐related mortality among 28,097 affected cases in UK Biobank
Zihuan Liu, Wei Dai, Shiying Wang, et al.
Genetic Epidemiology (2023) Vol. 47, Iss. 3, pp. 215-230
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top